News

Medtronic plc, announced positive clinical outcomes from two studies in atrial fibrillation patients treated with the Affera™ family of technologies, including the next-generation Sphere-360™ single-shot pulsed field ablation catheter and the...

Long-term data from the Volt CE Mark Study show strong results out to 12 months in patients receiving pulsed field ablation (PFA) therapy with the Volt™ PFA System. The 12-month results of the Volt CE Mark Study confirm the long-term safety...

Kardium Inc., a private medical device company that’s advancing the way the world treats atrial fibrillation (AF), announced late-breaking, one-year clinical trial results for its innovative pulsed field ablation (PFA) device—the Globe PF...

A new study, TRANSFORM-AF, found that patients with atrial fibrillation (AF) and obesity who were treated with a glucagon-like peptide-1 receptor agonist (GLP-1 RA) experienced a reduction in AF-related events, including hospitalization,...

Findings from two late-breaking clinical trials demonstrate the safety and efficacy of left bundle branch area pacing (LBBAP), adding to the growing body of evidence supporting new pacing methods.

A new study using data from the National Institutes of Health’s (NIH) All of Us Research Program found that artificial intelligence (AI) may be able to predict the risk of hospitalization from wearable fitness tracker data. Researchers...

A new study focused on athletes as a patient population showed that those with uncommon complex ventricular arrhythmia (VA) patterns were more likely to have structural heart disease and were at higher risk of sudden death. Researchers...

Adding to the Medtronic portfolio of catheter-based lead solutions, the novel OmniaSecure defibrillation lead allows for precise delivery and placement in the right ventricle

Omny-IRE data demonstrated the investigational OMNYPULSE™ Platform achieved 100% acute success and 84.5% pulmonary vein isolation (PVI) durability at three months, with promising safety outcomes1

New investment fuels growth of ECG-AI platform and development of perioperative AI capabilities